Diseases & Illness | Heart & Respiratory

Heart Valve Disease News

Fen-Phen Settlement One Step Closer

RSS News Feeds
Disease from Products
COX-2 / Arthritis
Bextra
Heart Valve Disease
Failure to Diagnose
Vioxx
 All RSS Feeds

At a glance:

A judge has approved a revised settlement between drugmaker Wyeth and those harmed by its fen-phen diet drug. 
 
According to these terms, Wyeth will deposit $1.275 billion into a new supplemental fund. 
 
Fen-phen, a mixture of Redux and Pondimin, was found to lead to heart valve damage and was withdrawn from the market in 1997. 
 
Wyeth has set aside $21 billion for costs and settlements.

Wyeth gets approval for new diet drug settlement

Reuters - 5/24/2006 9:12 AM

BOSTON (Reuters) - Wyeth (WYE.N: Quote, Profile, Research) said on Wednesday that it has received final judicial approval for a revised legal settlement related to its withdrawn "fen-phen" diet drugs.
 
The company said the agreement creates a new supplemental fund, into which Wyeth will ultimately deposit $1.275 billion
 
· Read The Full Heart Valve Disease Article From Reuters -->

· Read All Heart Valve Disease News Stories -->

Comments On Heart Valve Disease News Articles:


No Current Comments
Posted by Admin on 3/20/2006

There are no current comments. Why not post one?

Leave a Comment:

Once you click the 'Save Comment' button, you will receive a verification email from our website. Be sure to change any spam settings to allow webmaster@lawsuitsearch.com as a trusted sender.
 
If you are already a member, you can Sign In Here.
 
You can create your own FREE user account that you can use to participate in our message boards, blogs, newsletters and other community activities such as this one. To get your FREE user account, click here.

Email Address:

Your Name:

Message Title:

Message: